Events ESMO 2021: KEYNOTE-716 Study By ONA Editor September 23, 2021 No Comments Share Tweet Pinterest LinkedIn Tumblr Email + Highlights on pembrolizumab in fully resected high-risk stage II melanoma: KEYNOTE-716 study Share. Twitter Facebook Pinterest LinkedIn Tumblr Email